Back to Search
Start Over
Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy.
- Source :
-
Current Therapeutic Research . 2022, Vol. 96, pN.PAG-N.PAG. 1p. - Publication Year :
- 2022
- Subjects :
- *COVID-19
*BISMUTH
*SALICYLATES
Subjects
Details
- Language :
- English
- ISSN :
- 0011393X
- Volume :
- 96
- Database :
- Academic Search Index
- Journal :
- Current Therapeutic Research
- Publication Type :
- Academic Journal
- Accession number :
- 158056931
- Full Text :
- https://doi.org/10.1016/j.curtheres.2022.100667